drugset / Trial / NCT05292677

Laryngeal Nerve Block for Chronic Cough

NCT05292677

Phase 4 Unknown 40 enrolled Eastern Virginia Medical School
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to study the potential benefit of treating chronic neurogenic cough by blocking the nerve responsible for the disease with an injection of local anesthetic/steroid mixture versus a placebo.

Timeline

Start
2021-07-21
Primary completion
2023-06-25
Completion
2023-06-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Epinephrine Other / unclassified Other
Subject Triamcinolone Acetonide Other / unclassified 40 mg/ml Other

Indications